Aehr Test Systems (AEHR) Competitors $16.84 -0.06 (-0.36%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$16.88 +0.04 (+0.24%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEHR vs. TXG, TRNS, EYPT, ALNT, LAB, CTKB, SENS, QSI, QTRX, and FEIMShould you be buying Aehr Test Systems stock or one of its competitors? The main competitors of Aehr Test Systems include 10x Genomics (TXG), Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Quanterix (QTRX), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry. Aehr Test Systems vs. Its Competitors 10x Genomics Transcat Eyepoint Pharmaceuticals Allient Standard BioTools Cytek Biosciences Senseonics Quantum-Si Quanterix Frequency Electronics Aehr Test Systems (NASDAQ:AEHR) and 10x Genomics (NASDAQ:TXG) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations. Do analysts rate AEHR or TXG? 10x Genomics has a consensus price target of $13.23, suggesting a potential upside of 1.13%. Given 10x Genomics' stronger consensus rating and higher probable upside, analysts plainly believe 10x Genomics is more favorable than Aehr Test Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aehr Test Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.0010x Genomics 1 Sell rating(s) 5 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.42 Do insiders and institutionals have more ownership in AEHR or TXG? 69.7% of Aehr Test Systems shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 6.2% of Aehr Test Systems shares are held by company insiders. Comparatively, 9.4% of 10x Genomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is AEHR or TXG more profitable? Aehr Test Systems has a net margin of -6.63% compared to 10x Genomics' net margin of -25.14%. Aehr Test Systems' return on equity of -0.15% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Aehr Test Systems-6.63% -0.15% -0.13% 10x Genomics -25.14%-23.22%-18.02% Which has more risk & volatility, AEHR or TXG? Aehr Test Systems has a beta of 2.35, suggesting that its share price is 135% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Does the media favor AEHR or TXG? In the previous week, 10x Genomics had 4 more articles in the media than Aehr Test Systems. MarketBeat recorded 10 mentions for 10x Genomics and 6 mentions for Aehr Test Systems. 10x Genomics' average media sentiment score of 0.70 beat Aehr Test Systems' score of 0.59 indicating that 10x Genomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aehr Test Systems 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 10x Genomics 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, AEHR or TXG? Aehr Test Systems has higher earnings, but lower revenue than 10x Genomics. Aehr Test Systems is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAehr Test Systems$58.97M8.54-$3.91M-$0.13-129.5410x Genomics$610.78M2.64-$182.63M-$1.30-10.06 Summary10x Genomics beats Aehr Test Systems on 9 of the 16 factors compared between the two stocks. Get Aehr Test Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for AEHR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEHR vs. The Competition Export to ExcelMetricAehr Test SystemsELEC MSRNG INST IndustryComputer SectorNASDAQ ExchangeMarket Cap$505.57M$6.64B$29.22B$9.53BDividend YieldN/A0.30%3.08%4.08%P/E Ratio-129.5325.7248.0923.80Price / Sales8.545.221,545.0188.12Price / Cash157.1852.0538.0757.96Price / Book4.105.897.415.55Net Income-$3.91M$297.53M$782.10M$259.03M7 Day Performance-22.54%-2.67%-3.64%-4.56%1 Month Performance11.30%4.32%-0.10%4.49%1 Year Performance17.03%32.73%52,642.36%18.05% Aehr Test Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEHRAehr Test Systems1.3478 of 5 stars$16.84-0.4%N/A+1.8%$505.57M$58.97M-129.5390Gap DownTXG10x Genomics3.6519 of 5 stars$14.64+3.8%$13.23-9.6%-33.5%$1.80B$610.78M-11.261,240Upcoming EarningsAnalyst ForecastShort Interest ↑Gap DownTRNSTranscat3.4276 of 5 stars$82.71-1.7%$112.20+35.7%-32.9%$770.69M$278.42M53.021,245Upcoming EarningsEYPTEyepoint Pharmaceuticals1.8961 of 5 stars$10.03-4.3%$25.67+155.9%+6.4%$690.16M$43.27M-4.16120News CoverageUpcoming EarningsALNTAllient2.3229 of 5 stars$39.91+0.4%$31.00-22.3%+38.5%$675.68M$529.97M67.652,525News CoveragePositive NewsUpcoming EarningsGap DownLABStandard BioTools3.4899 of 5 stars$1.42+1.4%$2.50+76.1%-8.5%$539.34M$174.43M-4.06620Positive NewsGap DownCTKBCytek Biosciences2.4837 of 5 stars$3.75+1.6%$5.60+49.3%-43.2%$474.98M$200.45M-41.66500Positive NewsUpcoming EarningsSENSSenseonics1.6036 of 5 stars$0.54-2.2%$1.55+187.0%+21.1%$353.34M$23.68M-4.1590QSIQuantum-Si2.6533 of 5 stars$1.79-7.3%$3.48+94.1%+47.6%$328.47M$3.06M-2.63150Upcoming EarningsGap DownQTRXQuanterix2.2425 of 5 stars$6.49+10.9%$13.50+108.0%-58.3%$324.20M$133.92M-4.99460Upcoming EarningsGap DownFEIMFrequency Electronics1.2428 of 5 stars$27.87-0.4%N/A+99.3%$271.12M$69.81M11.28200Short Interest ↑Gap DownHigh Trading Volume Related Companies and Tools Related Companies TXG Competitors TRNS Competitors EYPT Competitors ALNT Competitors LAB Competitors CTKB Competitors SENS Competitors QSI Competitors QTRX Competitors FEIM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEHR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aehr Test Systems Please log in to your account or sign up in order to add this asset to your watchlist. Share Aehr Test Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.